Profile data is unavailable for this security.
About the company
Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.
- Revenue in EUR (TTM)22.27m
- Net income in EUR-21.42m
- Incorporated2002
- Employees233.00
- LocationMedian Technologies SALes Deux Arcs - Batiment B 1800Route des CretesVALBONNE 06560FranceFRA
- Phone+33 493333777
- Fax+33 492906599
- Websitehttps://mediantechnologies.com/
| Holder | Shares | % Held |
|---|---|---|
| Apo Asset Management GmbHas of 28 Mar 2024 | 560.53k | 3.05% |
| Herald Investment Management Ltd.as of 31 Dec 2023 | 522.35k | 2.84% |
| Aguja Capital GmbHas of 30 Jun 2023 | 512.69k | 2.79% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 412.66k | 2.25% |
| Discover Capital GmbHas of 30 Jun 2023 | 100.00k | 0.54% |
| Lonvia Capital SASUas of 30 Jun 2023 | 96.18k | 0.52% |
| Mandarine Gestion SAas of 30 Jun 2023 | 80.00k | 0.44% |
| Cholet Dupont Asset Management SAas of 30 Jun 2023 | 76.23k | 0.42% |
| Pure Capital SAas of 31 Dec 2023 | 68.29k | 0.37% |
| G�n�rali Investments Partners SpA SGR (France)as of 28 Feb 2022 | 65.00k | 0.35% |
